Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
Clinical trial NCT00487630 · UNKNOWN
Trial details
- NCT number
- NCT00487630
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.